The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET Scan
Public ClinicalTrials.gov record NCT01238588. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT01238588
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Brigham and Women's Hospital
- Other
- Enrollment
- 24 participants
Conditions and interventions
Interventions
- Sevelamer Carbonate (Renvela) Drug
Drug
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 9, 2011
- Primary completion
- Apr 7, 2016
- Completion
- Apr 7, 2016
- Last update posted
- Jul 30, 2017
2011 – 2016
United States locations
- U.S. sites
- 10
- U.S. states
- 1
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
| Fresenius Boston-TKC | Boston | Massachusetts | 02215 | — |
| BWH/FH/DCI Outpatient Dialysis Unit | Boston | Massachusetts | — | — |
| Fresenius Framingham (#1109) | Framingham | Massachusetts | 01701 | — |
| Fresenius Marlborough (#3448) | Marlborough | Massachusetts | 01752 | — |
| Fresenius Medford Dialysis (#1246) | Medford | Massachusetts | 02155 | — |
| Fresenius Quincy (#1610) | Quincy | Massachusetts | 02169 | — |
| Fresenius Roxbury (#1630) | Roxbury | Massachusetts | 02119 | — |
| DCI Dialysis Unit-Somerville | Somerville | Massachusetts | 02145 | — |
| Fresenius QCDC-Weymouth (#9144) | Weymouth | Massachusetts | 02190 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01238588, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 30, 2017 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01238588 live on ClinicalTrials.gov.